MGP Ingredients Q4 Adj. EPS $1.64 Beats $1.36 Estimate, Sales $214.89M Beat $205.39M Estimate
Portfolio Pulse from Benzinga Newsdesk
MGP Ingredients (NASDAQ:MGPI) reported Q4 adjusted EPS of $1.64, surpassing the $1.36 estimate, a 62.38% increase from last year. Sales reached $214.89M, beating the $205.39M estimate, marking a 12.51% increase from the previous year.

February 22, 2024 | 12:35 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
MGP Ingredients reported a significant beat on both EPS and sales estimates for Q4, indicating strong financial performance.
Beating both EPS and sales estimates by notable margins suggests robust financial health and operational efficiency. This outperformance, especially the significant year-over-year growth in earnings and sales, is likely to instill investor confidence and could lead to a positive short-term impact on MGPI's stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100